Ribon instrument patent door like the same root of the same root fry why too urgent

Click to view the latest quotes a stone stirred thousand layers of waves.　　From the analyst recommend cattle stocks, to the 2011 gem of the first purchase multiples of the last one, the state instrument only a day's time. Hand the Ribon instrument to the edge of the cliff, only the eve of the purchase of the company issued a notice book.　　And the director of all this, is the Ribon instrument's ' old acquaintance '----------　　April 12, is about to log on to the gem Shenzhen Precision Instruments Co., Ltd. issued a notice, said that Shenzhen, the Biological Medical Electronics Co., Ltd. has been on April 8 to the Shenzhen Intermediate People's Court, the identification of the state-instrument multi-parameter monitoring products violated its own intellectual property rights. To this end, the state instrument special in the announcement clarified: "The company's related monitoring products independent research and development has not violated the company's patent." However, it was this clarification announcement that pushed Ribon instruments into the depths of market skepticism.　　Announcement Day, the media reported a flood of news, and this day (April 13) is the Ribon instrument financing tour of the most critical journey-new shares purchase.　　"Old friendships" are originally from the same root?　　On the surface, a paper clarification bulletin catalyzed the market's questioning, but the director of all this, naturally, is the plaintiff of the patent infringement case---------------. Along with the investigation, Mai Rui biological and state instruments "puzzled origin" gradually surfaced.　　Curiously, the two companies that have been in court are "teachers", and they have a common name behind them--medical care. 1995, Zhang Hao, Shesi, Lu Liang each invested 667,000 yuan to set up the RIBON instrument predecessor State Limited, 5 years later, the incumbent director Zu Yudong investment shares.　　Since 2003, the original shareholder Lu Liang choose to leave, until now, by Zhang Hao, Shesi, Zu Yudong composed of "three corps" has always been the most core Ribon instrument leadership team. According to the prospectus, Zhang, Xie, Zu Sansin the first three major shareholders in the state instrument.　　Prior to the release, the three-person shareholding total Jianli State instrument total capital of more than 77%, even after the issuance of the implementation of their total holdings also accounted for about 57.8% of total equity.　　Although the time is different, holding total is poor, but as the soul of the state instrument, Zhang, Xie, the three ancestors have a common experience--to enter the state instrument before, are employed in Shenzhen medical equipment company.　　Among them, chairman Zhang Hao has been a company development engineers, Materials Engineers, Sales department deputy manager, director of Shesi has been a research and development engineers, research and development project manager, and the last shareholder of Zu Yudong has been the market and clinical technical support engineer, Ultrasound department marketing manager.　　Coincidentally, as the Chinese mainland veteran medical device enterprises, not only the training of the RIBON instrument of the leadership, in fact, the lawsuit against the state instrument patent infringement of the living creature, its current chairman Xuhang also from the department. After graduating from the Master's degree in 1987, Xuhang served in the department, until 1991 participated in the founding of the Shenzhen, the founder of the life, only to be in Mai Rui Company, and since then become the publicChief leader of the division. It is worth mentioning that the origins of the state apparatus and the life of the creature.　　In the list of top five clients in the Ribon instrument home market, the new financial journalist was surprised to find the name of the creature. According to the information provided by Ribon, in 2008 and 2009, Mai Rui Biological is the RIBON instrument in the mainland market, the largest customer.　　In 2008, Ribon's sales amounted to 4.2419 million yuan, which accounted for 2.44% of the main income of the year. Until 2010, Hunan Province Health department to up to 8.05 million yuan of purchase orders, only to replace the Mary Bio-state instruments of the largest mainland customers.　　Even so, the agent of the second-largest client of the state instrument last year still belonged to Mary.　　What's the rush of "New grudge"? More than 10 years later, the common prop up the domestic medical device market vast world of Ribon and Mary, had to go to court.　　Analysts believe that the competition for profits has led two of companies to quarrel. According to the underwriter's introduction, as early as 2009, the state instruments maternity products market share has ranked first in the country, the heart electric products home brand market share first.　　In addition, the state instruments of the heart electrical products accounted for the first export market share, guardianship products accounted for the third export market share. Ribon instrument in the prospectus admits: "The health care products involved in guardianship, clinical testing, digital ultrasound, radiological imaging, veterinary equipment and other fields, in the field of monitoring and digital ultrasound with the company to form a competitive relationship." In fact, in last year's Local government procurement tender list, the reporter repeatedly found the figure of both Mary and the state.　　Among them, the 2010 Nanjing Government Procurement Center "monitor, ventilator, anesthesia machine and other online public bidding results", there will be 7 of the MEC-1000 and other products, as well as Ribon instruments M8, M9 and other 6 products. "Ribon is perfectly capable of replicating the successful model of success, and as a leader in two industry, the ongoing commitment to research and development is guaranteed for international market share."　　"Qilu Securities analyst thank anti-trust mechanisms optimistic evaluation after the listing of the state instruments." Of course, with the success of the state instruments, in the face of limited market space, successful landing on the Nasdaq, and did not choose to sit still.　　April 8, a paper petition will Ribon sent to the dock at the same time, also make Ribon a A-share trip into an embarrassing way.　　Mary Biology pointed out that the state instruments M8, M9, M80 and M50 patient monitor for patent infringement, demand that it immediately stop the infringement, and payment of the total amount of 25 million of the compensation. On the question of infringement, the state instruments in the first time to make an explanation.　　Ribon that the company does not involve infringement, even if the lost, related technology in its operating income accumulation accounted for only 24.23%, does not affect the company's continued profitability. However, the plaintiff does not agree with the state of the algorithm.　　Mary claimed that the state instruments allegedly infringing products sales revenue amounted to 108 million yuan, accounting for its main business sales revenue of 33.88%. According to the new financial reporter's understanding, 2010, the state instrument monitoringThe total sales amount of the products is nearly 108 million yuan, which accounted for 33.88% of the gross income.　　In other words, if the idea of a Ribon is set up, it is likely that all the products in the main business of the instrument will involve infringement. It is worth mentioning that the M3 and h100b in the state instrument monitoring products have not been sued by the creature.　　These two technologies have been launched as early as 2008, and in the year for Ribon contributed 4.5451 million yuan sales revenue. As of press, the case was not implemented because of the judge, not into the actual trial stage, the state instruments whether the infringement is not conclusive.　　But no matter the lawsuit wins or loses, Ribon already paid the price. According to Ribon instrument April 14 Evening released the news, its initial public offering a shares online, the total frozen capital of 25.401 billion yuan. Among them, the network under the purchase multiples of about 3.9 times times, in the 2011-year gem number of new shares to the bottom of the ranking.